| Dr Karrin E Licht, MD | |
|
1501 W Chisholm St, Alpena, MI 49707-1401 | |
| (989) 340-1211 | |
| (989) 349-1214 |
| Full Name | Dr Karrin E Licht |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 1501 W Chisholm St, Alpena, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780620070 | NPI | - | NPPES |
| 4529425 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4301073974 (Michigan) | Primary |
| 208000000X | Pediatrics | 4301073974 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Michigan Medicine And Pediatrics Pllc | 0345218392 | 7 |
News Archive
The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration with Denali Therapeutics Inc. to develop novel therapies for Alzheimer's and other neurodegenerative diseases.
Heart surgeons at Johns Hopkins have evidence to support further tightening rather than easing of standards used to designate hospitals that are best at performing heart transplants.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold's small molecule hypoxia-targeted drug.
› Verified 3 days ago
| Entity Name | Northern Michigan Medicine And Pediatrics Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528168895 PECOS PAC ID: 0345218392 Enrollment ID: O20040917001131 |
News Archive
The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration with Denali Therapeutics Inc. to develop novel therapies for Alzheimer's and other neurodegenerative diseases.
Heart surgeons at Johns Hopkins have evidence to support further tightening rather than easing of standards used to designate hospitals that are best at performing heart transplants.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold's small molecule hypoxia-targeted drug.
› Verified 3 days ago
| Entity Name | Hospitalist Medicine Physicians Of Michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013180181 PECOS PAC ID: 4486703170 Enrollment ID: O20090529000290 |
News Archive
The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration with Denali Therapeutics Inc. to develop novel therapies for Alzheimer's and other neurodegenerative diseases.
Heart surgeons at Johns Hopkins have evidence to support further tightening rather than easing of standards used to designate hospitals that are best at performing heart transplants.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold's small molecule hypoxia-targeted drug.
› Verified 3 days ago
| Entity Name | Sound Inpatient Physicians-michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639311996 PECOS PAC ID: 5395896849 Enrollment ID: O20090624000252 |
News Archive
The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration with Denali Therapeutics Inc. to develop novel therapies for Alzheimer's and other neurodegenerative diseases.
Heart surgeons at Johns Hopkins have evidence to support further tightening rather than easing of standards used to designate hospitals that are best at performing heart transplants.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold's small molecule hypoxia-targeted drug.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karrin E Licht, MD Po Box 6514, Traverse City, MI 49696-6514 Ph: (989) 340-1211 | Dr Karrin E Licht, MD 1501 W Chisholm St, Alpena, MI 49707-1401 Ph: (989) 340-1211 |
News Archive
The University of Texas MD Anderson Cancer Center today announced a strategic research collaboration with Denali Therapeutics Inc. to develop novel therapies for Alzheimer's and other neurodegenerative diseases.
Heart surgeons at Johns Hopkins have evidence to support further tightening rather than easing of standards used to designate hospitals that are best at performing heart transplants.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold's small molecule hypoxia-targeted drug.
› Verified 3 days ago
Manuel Chavarri, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 346 Long Rapids Plz, Alpena, MI 49707 Phone: 989-358-3500 | |
Dr. Daniel L Maxwell, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 W Chisholm Street, Alpena, MI 49707 Phone: 989-356-8089 Fax: 989-356-8047 | |
Dr. Rohit Mahajan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 W Chisholm St, Alpena, MI 49707 Phone: 989-340-1211 Fax: 989-340-1214 | |
Dr. Christopher F Gerling, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 W Chisholm St, Alpena, MI 49707 Phone: 989-340-1211 Fax: 989-340-1214 | |
Dr. Abraham S Salacata, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 Long Rapids Plz, Alpena, MI 49707 Phone: 989-356-0141 Fax: 989-354-5670 | |
Dr. Keith J. Moody, D.O Internal Medicine Medicare: Medicare Enrolled Practice Location: 1501 W Chisholm St, Alpena, MI 49707 Phone: 989-340-1211 Fax: 989-340-1214 | |
Dr. Donald Miller, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Long Rapids Rd, Alpena, MI 49707 Phone: 989-356-2194 |